Q3 2024 · 13F-HR
FCPM III SERVICES B.V.holdings as filed
Filed 2024-11-14 · accession 0000950123-24-011523
$582.3M
Reported value
7
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $213.9M | 36.7% | 5,954,069 | Common | SHARED |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $196.4M | 33.7% | 11,831,461 | Common | SHARED |
| 29286M105 | — | ENGENE HOLDINGS INC | $57.3M | 9.84% | 8,677,951 | Common | SHARED |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $53.3M | 9.16% | 4,866,449 | Common | SHARED |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $53.0M | 9.09% | 2,339,961 | Common | SHARED |
| 29286M113 | — | ENGENE HOLDINGS INC | $6.0M | 1.04% | 2,878,148 | Common | SHARED |
| 00449L102 | 698 | ACHILLES THERAPEUTICS PLC | $2.4M | 0.42% | 2,390,050 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.